Intended for healthcare professionals

  1. Elisabeth Mahase
  1. The BMJ

People living with chronic pain should be offered a trial of non-inhaled medical cannabis or cannabinoids if standard care is not sufficient, a panel of international experts has said.1

The guideline panel—which reviewed the evidence as part of The BMJ’s Rapid Recommendations initiative —noted that it is a “weak recommendation” because of the close balance between benefits and harms, as well as the high value placed on small to very small …

View Full Text

Log in

Log in through your institution

Subscribe

* For online subscription